NCT03837418

Brief Summary

The purpose of this study is to create a human-readable and executable computer language to implement medical prescriptions and to evaluate and refine this language, with the goal of improving safety and efficacy of patient care

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
1mo left

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Jan 2019Jun 2026

Study Start

First participant enrolled

January 17, 2019

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

February 8, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 12, 2019

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

October 9, 2020

Status Verified

October 1, 2020

Enrollment Period

3.4 years

First QC Date

February 8, 2019

Last Update Submit

October 7, 2020

Conditions

Keywords

Patient-OrientedDesigningPrescriptions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of Differences between Ideal and Actual Performance of Prescriptions by Number of Deviations between Sequences of Events

    Investigators will express the intent of prescriptions in prescription programming language. Investigators will then compare the actual performance of the prescription in a clinical environment to the performance of the prescription in a simulated environment based on the same inputs as occurred in the real clinical environment.

    2 years

Eligibility Criteria

Age0 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients seen at Northwestern Memorial Hospital, Northwestern Medicine Clinics, Lurie Children's Clinics, and Lurie Children's Hospital between the ages of 0-79.

You may qualify if:

  • Patients seen at Northwestern Memorial Hospital, Northwestern Medicine Clinics, Lurie Children's Clinics, and Lurie Children's Hospital between the ages of 0-79.

You may not qualify if:

  • Patients without data within the NMEDW medical record database or LCH CDW or BIS medical record database.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern University

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Conditions

Language

Condition Hierarchy (Ancestors)

CommunicationBehavior

Study Officials

  • Steven M Belknap, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor of Dermatology

Study Record Dates

First Submitted

February 8, 2019

First Posted

February 12, 2019

Study Start

January 17, 2019

Primary Completion

June 1, 2022

Study Completion (Estimated)

June 1, 2026

Last Updated

October 9, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations